A termék adatai:
ISBN13: | 9780323952583 |
ISBN10: | 0323952585 |
Kötéstípus: | Puhakötés |
Terjedelem: | 350 oldal |
Méret: | 234x190 mm |
Súly: | 450 g |
Nyelv: | angol |
700 |
Témakör:
Operációs rendszerek és grafikus felhasználói felületek
Irodai szoftverek, táblázatkezelők
Az ember-gép kölcsönhatás
Operációs rendszerek és grafikus felhasználói felületek (karitatív célú kampány)
Irodai szoftverek, táblázatkezelők (karitatív célú kampány)
Az ember-gép kölcsönhatás (karitatív célú kampány)
Advances in Cancer Biomarkers Research
Kiadó: Academic Press
Megjelenés dátuma: 2024. december 13.
Normál ár:
Kiadói listaár:
EUR 144.00
EUR 144.00
Az Ön ára:
49 110 (46 771 Ft + 5% áfa )
Kedvezmény(ek): 20% (kb. 12 277 Ft)
A kedvezmény érvényes eddig: 2024. december 31.
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
Kattintson ide a feliratkozáshoz
Beszerezhetőség:
Még nem jelent meg, de rendelhető. A megjelenéstől számított néhány héten belül megérkezik.
Hosszú leírás:
Advances in Cancer Biomarkers Research provides a thorough and detailed description of cancer biomarkers for diagnostic, prognostic and therapeutics in several cancer types. The book presents a compendium of topics related to current advanced research, along with fundamental knowledge that will help readers fully comprehend the field of cancer biomarkers. Topics discussed include such the role of genetic mechanisms, epigenetics, DNA and microRNA in different cancers, signaling pathways and exosomes. In addition, the book discusses biomarker research applied to several cancer types, such as head and neck, urological, lung, bone tumors, hematological and neurological malignancies and breast cancers.This will be a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of biomarkers in cancer research and treatment.
Tartalomjegyzék:
1. Emerging role of biomarker in different cancers
2. Role of genetic mechanism in cancer
3. Role of epigenetics, DNA metylation, histone modification and microRNA in different cancers
4. Signaling pathways in prospective of biomarker development
5. Exosomes: Current and novel biomarkers tools for clinical diagnosis in early stage of cancer
6. Role of epigenetics in Breast Cancer: Current status and future perspectives
7. Current epigenetic and exosomal biomarkers in Gastrointestinal Cancers
8. Current epigenetic and exosomal biomarkers in Urological Cancers
9. Current epigenetic and exosomal biomarkers in Head and Neck Cancers
10. Current epigenetic and exosomal biomarkers in Lung Cancers
11. Genetic, epigenetic and exosomal biomarkers in haematological malignancies
12. Genetic, epigenetic and exosomal biomarkers in bone tumors
13. Genetic, epigenetic and exosomal biomarkers in neurological malignancies
14. Role of tumor-derived exosomes as early biomarkers in non-small cell lung cancer and its clinical implications
15. Role of Extracellular Vesicles in Renal Cell Carcinoma
16. Role of microRNAs and mRNAs in breast and lung cancer
17. Role of epigenetics in tumor hypoxia
2. Role of genetic mechanism in cancer
3. Role of epigenetics, DNA metylation, histone modification and microRNA in different cancers
4. Signaling pathways in prospective of biomarker development
5. Exosomes: Current and novel biomarkers tools for clinical diagnosis in early stage of cancer
6. Role of epigenetics in Breast Cancer: Current status and future perspectives
7. Current epigenetic and exosomal biomarkers in Gastrointestinal Cancers
8. Current epigenetic and exosomal biomarkers in Urological Cancers
9. Current epigenetic and exosomal biomarkers in Head and Neck Cancers
10. Current epigenetic and exosomal biomarkers in Lung Cancers
11. Genetic, epigenetic and exosomal biomarkers in haematological malignancies
12. Genetic, epigenetic and exosomal biomarkers in bone tumors
13. Genetic, epigenetic and exosomal biomarkers in neurological malignancies
14. Role of tumor-derived exosomes as early biomarkers in non-small cell lung cancer and its clinical implications
15. Role of Extracellular Vesicles in Renal Cell Carcinoma
16. Role of microRNAs and mRNAs in breast and lung cancer
17. Role of epigenetics in tumor hypoxia